Ovid Therapeutics (OVID) traded down -0.23 % during a 24 hours period ending at 01:15 PM Central Europe on Tuesday 27th. One Ovid Therapeutics stock can currently be bought for about USD 2.15 on popular exchanges. Current supply of Ovid Therapeutics stocks is 192.6 mn. Ovid Therapeutics has a current market capitalization of USD 420.9 mn and approximately USD 1.8 mn worth of Ovid Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Ovid Therapeutics has traded -12.4 % down. Simple moving average of last 200 days is at USD 2.35. The highest price of past 52 weeks was recorded at USD 3.1 on 04/09/2026. 52 weeks low was at USD 1.18 on 11/14/2025.
Here is how related stocks have performed in the past 24 hours:
Indaptus Therapeutics (INDP) traded up 5.7 % and now trades at USD 3.34. Current market capitalisation for Indaptus Therapeutics is USD 499.1 mn.
Delcath (DCTH) traded up 0.62 % and now trades at USD 14.51. Current market capitalisation for Delcath is USD 499 mn. Delcath has a current price to earnings ratio of 976.87.
Farmers & Merchants Banco/oh (FMAO) traded up 0.74 % and now trades at USD 36.81. Farmers & Merchants Banco/oh has a market capitalisation of USD 503.1 mn. Current price/earnings ratio for Farmers & Merchants Banco/oh is 12.46.
Cytomx Therapeutics (CTMX) traded down -4.09 % and now trades at USD 2.22. Cytomx Therapeutics has a market capitalisation of USD 497.9 mn.
Aquestive Therapeutics (AQST) traded down -0.75 % and now trades at USD 3.97. Current market capitalisation for Aquestive Therapeutics is USD 498.7 mn.
About Ovid Therapeutics
Ovid Therapeutics Inc. is a biopharmaceutical company that specializes in developing medications for patients and families living with rare neurological disorders. The company operates in the Health Care sector and is listed on the Nasdaq stock exchange. Their website is www.ovidrx.com , and they held their Initial Public Offering (IPO) on May 5, 2017.
